Global Chronic Obstructive Pulmonary Disorder Market - Growth, Trends and Forecasts 2017 - 2022

  • ID: 4388562
  • Report
  • Region: Global
  • 211 pages
  • Mordor Intelligence
1 of 4
The global COPD therapeutics market is expected to grow at a CAGR of XX% during the forecast period 2016-2021. The market was estimated to be USD XX million in 2015 and is forecasted to reach USD XX million by 2021.

The growth of the global chronic obstructive pulmonary disease (COPD) market is expected to be fueled by a high number of new, more efficacious and convenient products entering the market and commanding a greater value compared to the therapies already existing in the market. Another major factor propelling the growth of the market is the introduction of novel innovations like ultrasonic nebulizers, which are superior to the existing jet nebulizers. The competitive environment is expected to intensify with an increase in product extensions, technological innovations, and an increase in the number of mergers and acquisitions. The market for COPD drugs shows potential opportunity in both developed and developing countries. Due to the effectiveness and advancements in technology, many companies are focusing and collaborating to develop innovative COPD drugs and treatments.

Global COPD Therapeutics - Market Dynamics

The report details several factors driving and restraining the market, some of which are discussed below.


Technological advancements (e.g. ultrasonic nebulizers)

Increasing global spending on medicines

Increasing tobacco and cigarette consumption


Increased pricing pressure

Patent expiries

Introduction of generic drugs in the market

Market Segmentation

The global COPD therapeutics market has been segmented by drug type and products. By drugs, the market is segmented into Short-Acting Bronchodilators, Corticosteroids, Methylxanthines, Long-Acting Bronchodilators and Phosphodiesterase-4 Inhibitors). The products segment consists of inhalers (MDI’s. DPI’s and SMI’s) and nebulizers (jet nebulizers, ultrasonic nebulizers). The market has been geographically segmented into North America, Europe, Asia-Pacific, and Rest of the World.

Major Companies in the Sector Include:

This Report Offers:

Market definition, along with identification of key drivers and restraints for the market.

Market analysis with region-specific assessments and competition analysis on a global and regional scale.

Identification of factors instrumental in changing the market scenario, rising prospective opportunities and identification of key companies that can influence the market on a global and regional scale.

Extensively researched competitive landscape section with profiles of major companies along with their strategic initiatives and market share.

Identification and analysis of the macro and micro factors that affect the industry on both global and regional scale.

A comprehensive list of key market players, along with the analysis of their current strategic interests and key financial information.

An ideal source material for industry consultants, manufacturers and other interested and allied parties to gain critical insight into the factors driving and restraining the market, in addition to opportunities, offered.
Note: Product cover images may vary from those shown
2 of 4
1.1 Study deliveratives
1.2 Market Definition
1.3 Sizing Units
1.4 Base Currency
1.5 Review and forecast period years
1.6 General Study Assumptions
1.7 Report Description
2.1 Introduction
2.2 Analysis Methodology
2.3 Study timeline
2.4 Study Phases
2.4.1 Secondary Research
2.4.2 Discussion Guide
2.4.3 Market Engineering & Econometric Model
2.4.4 Expert Validation
5.1 Current market scenario
5.2 Market Overview
5.3 Porters Five Force Analysis
5.3.1 Bargaining Power Of Suppliers
5.3.2 Bargaining Power Of Buyers
5.3.3 Degree Of Competition
5.3.4 Threat Of Substitution
5.3.5 Threat Of New Entrants
6.1 Market Drivers
6.1.1 Technological advancements (e.g. ultrasonic nebulizers)
6.1.2 increasing global spending on medicines
6.1.3 increasing tobacco and cigarette consumption
6.2 Market Restraints
6.2.1 increased pricing pressures,
6.2.2 patent expiries
6.2.3 introduction of generic drugs in the market
6.3 Market opportunities
6.4 Key Challenges
7. Global COPD Therapeutics Market - Segmentation
7.1.1 Short-Acting Bronchodilators
7.1.2 Corticosteroids
7.1.3 Methylxanthines
7.1.4 Long-Acting Bronchodilators
7.1.5 Phosphodiesterase-4 Inhibitors
7.2.1 Inhalers Metered-Dose Inhalers (MDI's) Dry Powder Inhalers (DPI's) Soft Mist Inhalers (SMI's)
7.2.2 Nebulizers Jet Nebulizers Ultrasonic Nebulizers
7.2.3 Others
8. Global COPD Therapeutics Market - Regional Shares and Forecast
8.1 North America
8.1.1 United States
8.1.2 Canada
8.1.3 Mexico
8.2 Europe
8.2.1 Germany
8.2.2 UK
8.2.3 France
8.2.4 Italy
8.2.5 Spain & Portugal
8.2.6 Scandinavia
8.2.7 Benelux
8.2.8 Rest of Europe
8.3 Asia-Pacific
8.3.1 China
8.3.2 Japan
8.3.3 India
8.3.4 Australia & New Zealand
8.3.5 South Korea
8.3.6 Rest of Asia-Pacific
8.4 The Middle East and Africa
8.4.1 GCC
8.4.2 South Africa
8.4.3 Rest of the Middle East and Africa
8.5 Latin America
8.5.1 Brazil
8.5.2 Argentina
8.5.3 Rest of Latin America
9. Competitive Landscape
9.1 Merger and Acquisition Analysis
9.2 New Product Launches
9.3 Agreements, Collaborations & Partnerships
10. Company Profiles
10.1 AstraZeneca
10.2 Boehringer Ingelheim
10.3 GSK
10.4 Novartis
10.5 Teva Pharmaceuticals
10.6 Ache Laboratorios Farmaceuticos
10.7 Almirall
10.8 Aquinox Pharmaceuticals
10.9 Ario Pharma
10.10 Asmacure
10.11 Astellas Pharma
10.12 BioMarck Pharmaceuticals
10.13 Others
11. Analyst Outlook for Investment Opportunities
12. Future Outlook of the Market
Note: Product cover images may vary from those shown
3 of 4


4 of 4
Note: Product cover images may vary from those shown
Order Online - visit: